Annual ROE
-59.16%
+5.45%+8.44%
December 31, 2023
Summary
- As of February 26, 2025, TARA annual return on equity is -59.16%, with the most recent change of +5.45% (+8.44%) on December 31, 2023.
- During the last 3 years, TARA annual ROE has fallen by -42.11% (-246.98%).
- TARA annual ROE is now -116.08% below its all-time high of 367.95%, reached on December 31, 2019.
Performance
TARA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-55.96%
-0.93%-1.69%
September 30, 2024
Summary
- As of February 26, 2025, TARA quarterly return on equity is -55.96%, with the most recent change of -0.93% (-1.69%) on September 30, 2024.
- Over the past year, TARA quarterly ROE has increased by +21.10% (+27.38%).
- TARA quarterly ROE is now -667.63% below its all-time high of -7.29%, reached on September 30, 2019.
Performance
TARA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
TARA ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +8.4% | +27.4% |
| 3 y3 years | -247.0% | +27.4% |
| 5 y5 years | +41.7% | +27.4% |
TARA ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -102.7% | +8.4% | -125.1% | +27.4% |
| 5 y | 5-year | -116.1% | +8.4% | -147.3% | +27.4% |
| alltime | all time | -116.1% | +41.7% | -667.6% | +27.4% |
Protara Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -55.96%(+1.7%) |
| Jun 2024 | - | -55.03%(-6.4%) |
| Mar 2024 | - | -58.80%(+18.3%) |
| Dec 2023 | -59.16%(-8.4%) | -49.71%(-35.5%) |
| Sep 2023 | - | -77.06%(+21.1%) |
| Jun 2023 | - | -63.62%(+19.2%) |
| Mar 2023 | - | -53.37%(+9.0%) |
| Dec 2022 | -64.61%(+121.4%) | -48.95%(+96.9%) |
| Sep 2022 | - | -24.86%(-2.9%) |
| Jun 2022 | - | -25.59%(-4.8%) |
| Mar 2022 | - | -26.87%(-0.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | -29.18%(+71.1%) | -27.05%(+8.6%) |
| Sep 2021 | - | -24.90%(+10.0%) |
| Jun 2021 | - | -22.63%(-2.9%) |
| Mar 2021 | - | -23.31%(-11.2%) |
| Dec 2020 | -17.05%(-104.6%) | -26.24%(-25.0%) |
| Sep 2020 | - | -34.98%(-31.1%) |
| Jun 2020 | - | -50.76%(+18.4%) |
| Mar 2020 | - | -42.86%(+69.3%) |
| Dec 2019 | 367.95%(-462.9%) | -25.32%(+247.3%) |
| Sep 2019 | - | -7.29% |
| Dec 2018 | -101.40% | - |
FAQ
- What is Protara Therapeutics annual return on equity?
- What is the all time high annual ROE for Protara Therapeutics?
- What is Protara Therapeutics annual ROE year-on-year change?
- What is Protara Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Protara Therapeutics?
- What is Protara Therapeutics quarterly ROE year-on-year change?
What is Protara Therapeutics annual return on equity?
The current annual ROE of TARA is -59.16%
What is the all time high annual ROE for Protara Therapeutics?
Protara Therapeutics all-time high annual return on equity is 367.95%
What is Protara Therapeutics annual ROE year-on-year change?
Over the past year, TARA annual return on equity has changed by +5.45% (+8.44%)
What is Protara Therapeutics quarterly return on equity?
The current quarterly ROE of TARA is -55.96%
What is the all time high quarterly ROE for Protara Therapeutics?
Protara Therapeutics all-time high quarterly return on equity is -7.29%
What is Protara Therapeutics quarterly ROE year-on-year change?
Over the past year, TARA quarterly return on equity has changed by +21.10% (+27.38%)